Urinary tract disease associated with chronic ketamine use

doi:10.1136/bmj.39562.711713.80

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

This article has a correction

Please see: Urinary tract disease associated with chronic ketamine use

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Angela M Cottrell, clinical research fellow1,
Rachel Athreeres, volunteer manager2,
Pete Weinstock, senior practitioner2,
Kate Warren, urology registrar3,
David Gillatt, consultant urological surgeon4

¹Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB
²Bristol Drug Project, Bristol BS2 8PE
³Weston General Hospital, Weston super Mare BS23 4TQ
⁴Bristol Urological Institute, Bristol

angecottrell{at}hotmail.com

Regarding the case study by Dhillon et al,1 we have seen an alarming increase in people presenting to urological services in South West England with bladder symptoms associated with chronic ketamine use. Two case series in Hong Kong and Canada have been published, but ketamine associated bladder pathology has not been reported in the UK.2 3

Over the past two years, nine …